Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
British Journal of Clinical Pharmacology|February 1, 1990
Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjectsS M Singhvi, H Y Pan, R A Morrison, et al.Antimicrobial Agents and Chemotherapy|August 1, 1984
Distribution of [14C]aztreonam in rat tissueS M Singhvi, C E Ita, J M Shaw, et al.Antimicrobial Agents and Chemotherapy|September 1, 1983
Metabolism and pharmacokinetics of aztreonam in healthy subjectsE A Swabb, S M Singhvi, M A Leitz, et al.Kidney International|June 1, 1984
Elimination kinetics of captopril in patients with renal failureK L Duchin, A M Pierides, A Heald, et al.Journal of Pharmaceutical Sciences|March 1, 1984
Quantitative determination of captopril in blood and captopril and its disulfide metabolites in plasma by gas chromatographyM S Bathala, S H Weinstein, F S Meeker, et al.Journal of Chromatography|February 24, 1989
High-performance liquid chromatographic method for the radiometric determination of [14C] bucromarone in human plasma utilizing non-radiolabeled bucromarone as an internal standardD W Everett, J E Foley, S M Singhvi, et al.Journal of Clinical Pharmacology|February 1, 1982
Effect of food on the bioavailability of captopril in healthy subjectsS M Singhvi, D N McKinstry, J M Shaw, et al.Antimicrobial Agents and Chemotherapy|August 1, 1984
Distribution of aztreonam into fetuses and milk of ratsS M Singhvi, C E Ita, J M Shaw, et al.Clinical Pharmacology and Therapeutics|April 1, 1982
Captopril kineticsK L Duchin, S M Singhvi, D A Willard, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Relative contribution of the gut, liver, and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs. In vivo and in vitro studiesR A Morrison, S M Singhvi, A E Peterson, et al.Pageof 4